Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer
about
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersRUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasionRunx2 contributes to the regenerative potential of the mammary epithelium.Computational analysis of the mesenchymal signature landscape in gliomas.Expression of Tumor-Related Macrophages and Cytokines After Surgery of Triple-Negative Breast Cancer Patients and its Implications.RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.RUNX1 and FOXP3 interplay regulates expression of breast cancer related genesNetDecoder: a network biology platform that decodes context-specific biological networks and gene activities.MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid CancerProgression inference for somatic mutations in cancer.Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast CancerRUNX1 and breast cancer.Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity.RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells.Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.is a RUNX1 target gene and promotes migration of NSCLC cellsBreast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity
P2860
Q30276341-558C3477-AF8B-427B-8610-691457D0471FQ35240492-A43A82DC-F524-4FC1-9A7C-B7DB5506E8B2Q35782827-87731F7B-7C30-4E32-A97E-0085C1508792Q36189136-0CA9E3BD-5199-47BD-BE3E-8AC54C788233Q36303247-A6330E6E-10A1-44BB-83EF-AC408ECB9AE1Q36462938-00B5E520-7C74-42D3-81E5-DA16E5A39ED4Q36637143-B660BD6A-6FAE-43F8-ABF1-68112A535972Q36916273-8BD6EDCE-D23D-4638-B339-7101CAFA4659Q36959048-7B5E9423-C8BB-47E0-8D85-C8BB08B36883Q37080584-ABE7BCBD-AC27-4413-BEB7-B4CB8A129283Q37085891-80A4F778-7CBF-49CD-A02D-757936355546Q37688549-6D95CE7F-00AE-4BB1-BF1E-0DD79A617E51Q38722836-FEAB8155-A4A3-4852-A6AE-4B017163A665Q38743681-1BF2FF08-C83E-4466-B32B-38E0C2A52722Q38766996-91303545-7A57-43EC-AE2F-B91B17699D22Q38793244-1166DC47-20ED-4D77-BF87-5CF57F9DEC14Q38883388-6134EA1A-8681-4C23-B46F-244791D50A01Q39647103-3FDBB8FC-C36C-4D9E-B6E0-C4845FBC0CFDQ40293334-D085EF23-5D76-49A4-AD21-880DF6400D7FQ41139971-AC2D4799-BF8C-4D44-87BA-B9861FDAF43EQ42334131-91881CCC-C209-4AE7-B11C-08CD5D602F70Q42334209-F1B2C4B7-5D68-491D-99C6-2164B79FB9A5Q42378493-E11690ED-9A84-45BF-BF19-02934CD2FCCEQ42709502-742BA016-41ED-43B3-8BC4-6D738E21C818Q48322745-A9C1A889-7376-4706-B70D-C4FC3F0E8CEBQ55355645-E1012E70-6F62-429B-AF18-7C563137D99FQ57815287-C1E36323-D806-482A-91EF-1527663C2D30Q58797665-CDF27929-7ADC-4379-9B3F-FFB08FC04126
P2860
Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expression of RUNX1 correlates ...... triple negative breast cancer
@ast
Expression of RUNX1 correlates ...... triple negative breast cancer
@en
type
label
Expression of RUNX1 correlates ...... triple negative breast cancer
@ast
Expression of RUNX1 correlates ...... triple negative breast cancer
@en
prefLabel
Expression of RUNX1 correlates ...... triple negative breast cancer
@ast
Expression of RUNX1 correlates ...... triple negative breast cancer
@en
P2093
P2860
P50
P1433
P1476
Expression of RUNX1 correlates ...... triple negative breast cancer
@en
P2093
Colin Nixon
Elizabeth Mallon
Ewan R Cameron
Joanna S Morris
Zahra M A Mohammed
P2860
P304
P356
10.1371/JOURNAL.PONE.0100759
P407
P577
2014-06-26T00:00:00Z